Physician profile
Rukmini Menon
NPI 1740443951
$18,175.93
in general payments reported to CMS, 2019-2025
64 companies · $5,476 in 2025
The $5,476 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $951 · 2021: $1,228 · 2022: $2,146 · 2023: $2,838 · 2024: $4,259 · 2025: $5,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,354.94 |
| Education | $218.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,977.46 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Abbvie INC. | $1,626.39 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $1,356.54 | 2019-2025 | Ultomiris, Soliris |
| Jazz Pharmaceuticals INC. | $1,117.56 | 2019-2025 | Xywav |
| Teva Pharmaceuticals USA, INC. | $875.43 | 2019-2024 | Austedo Xr, Austedo |
| Argenx US, INC. | $712.64 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Mdd US Operations, LLC | $692.76 | 2019-2025 | Gocovri, Gocovri |
| Pfizer INC. | $640.45 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $593.62 | 2019-2025 | |
| Harmony Biosciences LLC | $581.94 | 2020-2025 | |
| Amgen INC. | $569.71 | 2019-2025 | Uplizna, Aimovig |
| Neurocrine Biosciences, INC. | $567.93 | 2022-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $443.50 | 2023-2025 | Vyepti |
| Neurelis, INC. | $388.62 | 2021-2025 | Valtoco |
| Supernus Pharmaceuticals, INC. | $366.32 | 2019-2022 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $346.99 | 2023-2025 | Sunosi, Symbravo |
| Avadel Cns Pharmaceuticals, LLC | $309.17 | 2024-2025 | Lumryz |
| Genentech USA, INC. | $301.53 | 2022-2024 | Ocrevus, Enspryng |
| Eisai INC. | $297.79 | 2023-2025 | |
| Inspire Medical Systems, INC. | $281.07 | 2024-2025 | Inspire |
| Lilly USA, LLC | $255.89 | 2022-2024 | Kisunla, Amyvid, Emgality |
| Grifols USA, LLC | $253.52 | 2023-2025 | Gamunex-C |
| Sunovion Pharmaceuticals INC. | $241.76 | 2020-2022 | |
| Biogen, INC. | $227.68 | 2022-2025 | Leqembi, Tysabri, Vumerity |
| Sk Life Science, INC. | $211.45 | 2020-2024 | |
| Merz Pharmaceuticals, LLC | $203.68 | 2021-2025 | Xeomin, Ampyra, Inbrija |
| Tg Therapeutics, INC. | $183.13 | 2023-2025 | |
| Acorda Therapeutics, INC | $170.24 | 2020-2024 | Inbrija |
| Otsuka America Pharmaceutical, INC. | $165.17 | 2023-2025 | Rexulti |
| Impel Pharmaceuticals INC. | $158.75 | 2023 | Trudhesa |
| Avion Pharmaceuticals | $158.47 | 2022-2023 | Dhivy |
| Merz North America, INC. | $144.07 | 2019-2020 | |
| Celgene Corporation | $129.48 | 2022-2025 | Zeposia |
| Averitas Pharma INC. | $123.30 | 2023 | Qutenza |
| Csl Behring | $116.93 | 2022-2024 | Hizentra |
| Allergan, INC. | $114.58 | 2019 | |
| Horizon Therapeutics Plc | $98.40 | 2023 | Uplizna |
| Livanova USA, INC. | $95.99 | 2019-2020 | |
| Genzyme Corporation | $93.83 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $71.90 | 2023-2025 | Dysport |
| Amneal Pharmaceuticals LLC | $71.63 | 2023 | Rytary, Lyvispah |
| Acadia Pharmaceuticals INC | $68.49 | 2022-2024 | Nuplazid |
| Janssen Pharmaceuticals, INC | $63.37 | 2022 | |
| Vanda Pharmaceuticals INC. | $62.80 | 2025 | Ponvory |
| Aquestive Therapeutics, INC. | $61.35 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.85 | 2024-2025 | Hyqvia |
| Alnylam Pharmaceuticals INC. | $54.31 | 2022-2024 | Onpattro |
| Sumitomo Pharma America, INC. | $52.94 | 2023 | Aptiom |
| Catalyst Pharmaceuticals, INC. | $52.65 | 2023-2024 | Firdapse |
| Ani Pharmaceuticals, INC. | $45.30 | 2024 | Purified Cortrophin Gel |
| Microtransponder, INC. | $34.98 | 2023 | |
| Collegium Pharmaceutical, INC. | $32.80 | 2022 | |
| Arbor Pharmaceuticals, INC. | $32.22 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.45 | 2022 | |
| Ge Healthcare | $25.11 | 2023 | |
| Corium, LLC | $23.35 | 2023 | Adlarity |
| Banner Life Sciences, LLC | $22.17 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.69 | 2024 | Dojolvi |
| Octapharma USA, INC. | $19.17 | 2023 | Panzyga |
| Medtronic, INC. | $19.06 | 2025 | Inceptiv |
| Astrazeneca Pharmaceuticals LP | $18.42 | 2025 | Wainua |
| Mallinckrodt Enterprises LLC | $18.32 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.98 | 2022 | |
| Emd Serono, INC. | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rukmini Menon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.